You are here

  • Home
  • Archive
  • Volume 76, Issue 9
  • Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease

Article metrics

Article menu

Download PDFPDF

Correspondence
Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease
Free

 

Online download statistics by month:

Online download statistics by month: January 2017 to May 2023

AbstractFullPdf
Jan 2017477463276
Feb 201760169204
Mar 2017511968
Apr 201706626
May 201757440
Jun 2017104526
Jul 2017434528
Aug 201733433093
Sep 201715915967
Oct 201710810560
Nov 2017747462
Dec 2017676758
Jan 2018646437
Feb 2018655934
Mar 20181009635
Apr 2018495024
May 2018636219
Jun 2018646614
Jul 2018666518
Aug 2018797729
Sep 2018494921
Oct 2018787820
Nov 2018545416
Dec 2018424211
Jan 2019555316
Feb 2019747231
Mar 2019757429
Apr 2019545214
May 2019676614
Jun 2019737130
Jul 2019605913
Aug 2019555214
Sep 2019625916
Oct 201944377
Nov 2019646325
Dec 2019524711
Jan 2020857830
Feb 2020767020
Mar 2020413919
Apr 2020434118
May 2020514917
Jun 2020595618
Jul 2020676513
Aug 2020403814
Sep 202060526
Oct 2020575112
Nov 202042399
Dec 202051486
Jan 202141418
Feb 2021575724
Mar 2021595917
Apr 2021585817
May 2021797615
Jun 202155546
Jul 202159599
Aug 2021494911
Sep 2021474610
Oct 2021716935
Nov 2021646218
Dec 2021565611
Jan 2022676512
Feb 202251517
Mar 2022798016
Apr 2022636320
May 2022858623
Jun 20221019922
Jul 202256599
Aug 202276729
Sep 2022646729
Oct 2022888813
Nov 2022696713
Dec 202258590
Jan 2023645911
Feb 2023706614
Mar 2023878213
Apr 202369699
May 2023646414
Total542856912103